ATE295185T1 - Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff - Google Patents

Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff

Info

Publication number
ATE295185T1
ATE295185T1 AT01980600T AT01980600T ATE295185T1 AT E295185 T1 ATE295185 T1 AT E295185T1 AT 01980600 T AT01980600 T AT 01980600T AT 01980600 T AT01980600 T AT 01980600T AT E295185 T1 ATE295185 T1 AT E295185T1
Authority
AT
Austria
Prior art keywords
fine particles
producing
active substance
host molecule
particles consisting
Prior art date
Application number
AT01980600T
Other languages
English (en)
Inventor
Michel Perrut
Jennifer Jung
Fabrice Leboeuf
Isabelle Fabing
Original Assignee
Separex Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8855510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE295185(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Separex Sa filed Critical Separex Sa
Application granted granted Critical
Publication of ATE295185T1 publication Critical patent/ATE295185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Extraction Or Liquid Replacement (AREA)
AT01980600T 2000-10-19 2001-10-19 Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff ATE295185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0013393A FR2815540B1 (fr) 2000-10-19 2000-10-19 Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
PCT/FR2001/003238 WO2002032462A1 (fr) 2000-10-19 2001-10-19 Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hôte

Publications (1)

Publication Number Publication Date
ATE295185T1 true ATE295185T1 (de) 2005-05-15

Family

ID=8855510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980600T ATE295185T1 (de) 2000-10-19 2001-10-19 Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff

Country Status (10)

Country Link
US (1) US7291296B2 (de)
EP (1) EP1330266B2 (de)
JP (1) JP2004511530A (de)
AT (1) ATE295185T1 (de)
AU (1) AU2002212412A1 (de)
CA (1) CA2426697A1 (de)
DE (1) DE60110824D1 (de)
ES (1) ES2241885T3 (de)
FR (1) FR2815540B1 (de)
WO (1) WO2002032462A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
GB9810559D0 (en) * 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
TW586963B (en) * 2001-07-20 2004-05-11 Nektar Therapeutics Uk Ltd Method and apparatus for preparing target substance in particulate form and fluid inlet assembly for said apparatus
FR2830760B1 (fr) * 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
MXPA05007154A (es) 2002-12-30 2005-09-21 Nektar Therapeutics Atomizador prepeliculizacion.
FR2854079B1 (fr) * 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
WO2004098561A2 (en) * 2003-05-08 2004-11-18 Nektar Therapeutics Uk Ltd Particulate materials
ATE504316T1 (de) * 2004-04-01 2011-04-15 Pf Medicament Einschlusskomplexe enthaltend piroxicam, ein cyklodextrin und arginin
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
FR2876914A1 (fr) * 2004-10-21 2006-04-28 Pierre Fabre Medicament Sa Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction
FR2876910B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
US8708159B2 (en) * 2011-02-16 2014-04-29 Oakwood Laboratories, Llc Manufacture of microspheres using a hydrocyclone
PL2699114T3 (pl) * 2011-04-22 2018-11-30 Pepsico, Inc. Kapsułkowanie ekstraktu w porowatych cząstkach
WO2013136974A1 (ja) * 2012-03-12 2013-09-19 シャープ株式会社 修飾微粒子の精製方法および製造方法、修飾微粒子、機能性材料、光学部材、熱伝部材、ならびに、被覆率分析装置および被覆率分析方法
CA2895816C (en) 2012-12-21 2021-02-23 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions
US9925512B2 (en) 2013-03-14 2018-03-27 Crititech, Inc. Equipment assembly for and method of processing particles
US8778181B1 (en) 2013-03-14 2014-07-15 Crititech, Inc. Equipment assembly for and method of processing particles
US10544049B2 (en) 2014-11-20 2020-01-28 Basf Se Process for preparing a porous inorganic powder
CN105343893B (zh) * 2015-12-11 2018-07-20 中国药科大学 对乙酰氨基酚-2-羟丙基-β-环糊精包合物制备方法
CN106265596B (zh) * 2016-10-12 2019-02-22 中国药科大学 超临界抗溶剂法制备柚皮素/羟丙基-β-环糊精微胶囊的方法
JP2020513049A (ja) 2017-04-13 2020-04-30 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 多孔質材料を製造する方法
IL292377B2 (en) * 2019-10-21 2023-11-01 Esolate Ltd Thin compounds and their production
CN116035908B (zh) * 2021-12-24 2026-03-20 中国人民解放军军事科学院军事医学研究院 一种用于制备球形药物微晶的雾化系统及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0819004B2 (ja) † 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201685B (en) † 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
DE3744329A1 (de) † 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
GB9313642D0 (en) † 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9413202D0 (en) † 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
ATE212545T1 (de) † 1995-03-28 2002-02-15 Fidia Advanced Biopolymers Srl Nanosphären mit einem biokompatiblen polysaccharid
AU709384B2 (en) * 1996-03-01 1999-08-26 University Of Kansas, The Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents
US5874029A (en) * 1996-10-09 1999-02-23 The University Of Kansas Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
GB9703673D0 (en) † 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
EP1073419A4 (de) † 1998-03-18 2009-03-25 Univ Technology Corp Zusammensetzung, enthaltend amorphes polymer, zur verzögerten freisetzung.
GB9810559D0 (en) * 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
GB9915975D0 (en) † 1999-07-07 1999-09-08 Bradford Particle Design Ltd Method for the formation of particles
GB9920558D0 (en) † 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
FR2798863B1 (fr) † 1999-09-27 2001-12-28 Separex Sa Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit

Also Published As

Publication number Publication date
DE60110824D1 (de) 2005-06-16
FR2815540A1 (fr) 2002-04-26
ES2241885T3 (es) 2005-11-01
EP1330266B2 (de) 2009-08-26
EP1330266B1 (de) 2005-05-11
JP2004511530A (ja) 2004-04-15
US20040119179A1 (en) 2004-06-24
EP1330266A1 (de) 2003-07-30
AU2002212412A1 (en) 2002-04-29
FR2815540B1 (fr) 2005-06-10
WO2002032462A1 (fr) 2002-04-25
US7291296B2 (en) 2007-11-06
CA2426697A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
DE60110824D1 (de) Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff
Sadeghi et al. Salting-in and salting-out of water-soluble polymers in aqueous salt solutions
Park et al. Microfluidic investigation of salinity-induced oil recovery in porous media during chemical flooding
Chun et al. Protein transport in nanoporous membranes modified with self-assembled monolayers of functionalized thiols
DE60141078D1 (de) Methode zur beschichtung feiner teilchen mit einem lipidfilm
ATE66947T1 (de) Verfahren zur herstellung von kleinen, sphaerischen polymerpartikeln.
Sheng et al. Thermal stability of gel foams stabilized by xanthan gum, silica nanoparticles and surfactants
ATE204787T1 (de) Verfahren zur herstellung eines pulverförmigen produktes aus einem flüssigen stoff oder stoffgemisch
Kalyankar et al. Applications of micellar liquid chromatography in bioanalysis: a review
CY1107306T1 (el) Μεθοδος παρασκευης μιας ενωσεως αλληλεπιδρασεως δραστικων ουσιων με ενα πορωδες υποστρωμα μεσω ενος υπερκρισιμου ρευστου
Nemati-Kande et al. Salting-out effect of sodium, potassium, carbonate, sulfite, tartrate and thiosulfate ions on aqueous mixtures of acetonitrile or 1-methyl-2-pyrrolidone: A liquid–liquid equilibrium study
Sthoer et al. Anion Specific Effects at Negatively Charged Interfaces: Influence of Cl–, Br–, I–, and SCN–on the Interactions of Na+ with the Carboxylic Acid Moiety
Nowik-Zajac et al. Removal of methylene blue dye from aqueous solutions using polymer inclusion membrane containing calix [4] pyrrole
Elek et al. Enantioselective capillary electrophoretic separation of tryptophane-and tyrosine-methylesters in a dual system with a tetra-oxadiaza-crown-ether derivative and a cyclodextrin
Ramezani et al. CO2-responsive low molecular weight polymer with high osmotic pressure as a draw solute for forward osmosis
Davantès et al. Impact of hydrophobic and electrostatic forces on the adsorption of Acacia gum on oxide surfaces revealed by QCM-D
ATE327823T1 (de) Verfahren zur herstellung von kolloidalen partikeln, die in form von nanokapseln sind
Sanli et al. Removal of Fe (III) ions from dilute aqueous solutions by alginic acid‐enhanced ultrafiltration
DE602004017448D1 (de) Verfahren zur tensid-quantifizierung eines proteinpräparates
Saha et al. Analysis of fouling characteristics and flux decline during humic acids batch ultrafiltration
Petr et al. Separation of ketoprofen enantiomers at nanomolar concentration levels by micellar electrokinetic chromatography with on-line electrokinetic preconcentration
DE602004029742D1 (de) Verfahren und Vorrichtung zur Herstellung von anorganischen Sphären
Dominguez et al. Scaling laws in the dynamics of collapse of single bubbles and 2D foams
Giraldo et al. Development and evaluation from laboratory to field trial of a dual-purpose fracturing nanofluid: inhibition of associated formation damage and increasing heavy crude oil mobility
Wan et al. Extracting natural biosurfactants from humus deposits for subsurface engineering applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties